Search
Search Results
-
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings
IntroductionWe aimed to assess the frequency, duration, and severity of area postrema syndrome (APS) during follow-up in neuromyelitis optica...
-
Area postrema syndrome with linear enhancement along the surface of the brainstem and fourth ventricle in autoimmune GFAP astrocytopathy
BackgroundGlial fibrillary acidic protein (GFAP) astrocytopathy, a novel autoimmune disease of the nervous system, was first defined in 2016. To our...
-
Clinical analysis of neuromyelitis optica spectrum disease with area postrema syndrome as the initial symptom
ObjectiveThe objective of this study was to report and discuss clinical analysis, including the diagnosis and treatment of 4 cases of neuromyelitis...
-
Area postrema neurons mediate interleukin-6 function in cancer cachexia
Interleukin-6 (IL-6) has been long considered a key player in cancer cachexia. It is believed that sustained elevation of IL-6 production during...
-
Symptomatic care of late-onset Alexander disease presenting with area postrema-like syndrome with prednisolone; a case report
BackgroundAlexander disease (AxD) is classified into AxD type I (infantile) and AxD type II (juvenile and adult form). We aimed to determine the...
-
Characteristics of recurrence in area postrema-onset NMO spectrum disorder - a retrospective cohort study
BackgroundNeuromyelitis Optica Spectrum Disorder (NMOSD) is an inflammatory autoimmune disease with high risk of recurrence and disability, the...
-
Area postrema syndrome in neuromyelitis optica spectrum disorder: diagnostic challenges and descriptive patterns
BackgroundAlthough area postrema syndrome (APS) is one of the core clinical features of neuromyelitis optic spectrum disorder (NMOSD), it is...
-
Autoimmune glial fibrillary acidic protein astrocytopathy presented as isolated area postrema symdrome: a case report
BackgroundArea postrema syndrome (APS) as the isolated manifestation in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy has been...
-
-
-
Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjögren’s syndrome: a systematic review of individual patient data
Central nervous system (CNS) involvement can occur in primary Sjögren’s syndrome (pSS) due to co-existing neuromyelitis optica spectrum disorder...
-
Stress cardiomyopathy associated with area postrema syndrome as a presentation of neuromyelitis optica: case report
BackgroundStress cardiomyopathy (Takotsubo cardiomyopathy) is very rare in the central nervous system (CNS) demyelinating disorders. Although this...
-
-
The spectrum of anti-GQ1B antibody syndrome: beyond Miller Fisher syndrome and Bickerstaff brainstem encephalitis
IntroductionSince the initial identification of Miller Fisher syndrome (MFS) and Bickerstaff brainstem encephalitis (BBE),significant milestones have...
-
Neurochemical Anatomy of Cushing’s Syndrome
The neurochemical anatomy underlying Cushing’s syndrome is examined for regional brain metabolism as well as neurotransmitter levels and receptor...
-
Gut Hormones and Metabolic Syndrome
The gastrointestinal tract has a critical role in energy homeostasis as the site of food ingestion, digestion, and absorption of nutrients. Neural...
-
Gut Hormones and Metabolic Syndrome
The gastrointestinal tract has a critical role in energy homeostasis as the site of food ingestion, digestion, and absorption of nutrients. Neural...
-
Clinical and prognostic aspects of patients with the Neuromyelitis Optica Spectrum Disorder (NMOSD) from a cohort in Northeast Brazil
IntroductionNeuromyelitis optica spectrum disorders (NMOSD) is a rare inflammatory and demyelinating disease of the central nervous system (CNS) more...
-
Longitudinally extensive transverse myelitis with trident sign and positive AQP4 antibody: a case report
BackgroundLongitudinally extensive transverse myelitis (LETM) is characterized by spinal cord lesions that affect at least three spinal cord...
-
First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder following the COVID-19 mRNA vaccine BNT162b2
BNT162b2 is one of the effective COVID-19 vaccines. However, some researchers have also reported some neurological adverse events after the...
